These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 34810247)

  • 1. Association of Neurofibrillary Tangle Distribution With Age at Onset-Related Clinical Heterogeneity in Alzheimer Disease: An Autopsy Study.
    Smirnov DS; Salmon DP; Galasko D; Goodwill VS; Hansen LA; Zhao Y; Edland SD; Léger GC; Peavy GM; Jacobs DM; Rissman R; Pizzo DP; Hiniker A
    Neurology; 2022 Feb; 98(5):e506-e517. PubMed ID: 34810247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alzheimer disease without neocortical neurofibrillary tangles: "a second look".
    Tiraboschi P; Sabbagh MN; Hansen LA; Salmon DP; Merdes A; Gamst A; Masliah E; Alford M; Thal LJ; Corey-Bloom J
    Neurology; 2004 Apr; 62(7):1141-7. PubMed ID: 15079014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alzheimer's disease clinical variants show distinct regional patterns of neurofibrillary tangle accumulation.
    Petersen C; Nolan AL; de Paula França Resende E; Miller Z; Ehrenberg AJ; Gorno-Tempini ML; Rosen HJ; Kramer JH; Spina S; Rabinovici GD; Miller BL; Seeley WW; Heinsen H; Grinberg LT
    Acta Neuropathol; 2019 Oct; 138(4):597-612. PubMed ID: 31250152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective Vulnerability of the Nucleus Basalis of Meynert Among Neuropathologic Subtypes of Alzheimer Disease.
    Hanna Al-Shaikh FS; Duara R; Crook JE; Lesser ER; Schaeverbeke J; Hinkle KM; Ross OA; Ertekin-Taner N; Pedraza O; Dickson DW; Graff-Radford NR; Murray ME
    JAMA Neurol; 2020 Feb; 77(2):225-233. PubMed ID: 31657834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropathologically defined subtypes of Alzheimer's disease differ significantly from neurofibrillary tangle-predominant dementia.
    Janocko NJ; Brodersen KA; Soto-Ortolaza AI; Ross OA; Liesinger AM; Duara R; Graff-Radford NR; Dickson DW; Murray ME
    Acta Neuropathol; 2012 Nov; 124(5):681-92. PubMed ID: 22968369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein contributions to brain atrophy acceleration in Alzheimer's disease and primary age-related tauopathy.
    Josephs KA; Martin PR; Weigand SD; Tosakulwong N; Buciuc M; Murray ME; Petrucelli L; Senjem ML; Spychalla AJ; Knopman DS; Boeve BF; Petersen RC; Parisi JE; Dickson DW; Jack CR; Whitwell JL
    Brain; 2020 Dec; 143(11):3463-3476. PubMed ID: 33150361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overlapping but distinct TDP-43 and tau pathologic patterns in aged hippocampi.
    Smith VD; Bachstetter AD; Ighodaro E; Roberts K; Abner EL; Fardo DW; Nelson PT
    Brain Pathol; 2018 Mar; 28(2):264-273. PubMed ID: 28281308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Artificial intelligence-derived neurofibrillary tangle burden is associated with antemortem cognitive impairment.
    Marx GA; Koenigsberg DG; McKenzie AT; Kauffman J; Hanson RW; Whitney K; Signaevsky M; Prastawa M; Iida MA; White CL; Walker JM; Richardson TE; Koll J; Fernandez G; Zeineh J; Cordon-Cardo C; Crary JF; Farrell K;
    Acta Neuropathol Commun; 2022 Oct; 10(1):157. PubMed ID: 36316708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TAR DNA-Binding Protein 43 Is Associated with Rate of Memory, Functional and Global Cognitive Decline in the Decade Prior to Death.
    Buciuc M; Tosakulwong N; Machulda MM; Whitwell JL; Weigand SD; Murray ME; Reichard RR; Parisi JE; Dickson DW; Boeve BF; Knopman DS; Petersen RC; Josephs KA
    J Alzheimers Dis; 2021; 80(2):683-693. PubMed ID: 33579840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced synchrony in alpha oscillations during life predicts post mortem neurofibrillary tangle density in early-onset and atypical Alzheimer's disease.
    Ranasinghe KG; Petersen C; Kudo K; Mizuiri D; Rankin KP; Rabinovici GD; Gorno-Tempini ML; Seeley WW; Spina S; Miller BL; Vossel K; Grinberg LT; Nagarajan SS
    Alzheimers Dement; 2021 Dec; 17(12):2009-2019. PubMed ID: 33884753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MRI correlates of neurofibrillary tangle pathology at autopsy: a voxel-based morphometry study.
    Whitwell JL; Josephs KA; Murray ME; Kantarci K; Przybelski SA; Weigand SD; Vemuri P; Senjem ML; Parisi JE; Knopman DS; Boeve BF; Petersen RC; Dickson DW; Jack CR
    Neurology; 2008 Sep; 71(10):743-9. PubMed ID: 18765650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural correlates of cognitive deficits in a selected group of patients with Alzheimer's disease.
    Caramelli P; Robitaille Y; Laroche-Cholette A; Nitrini R; Gauvreau D; Joanette Y; Lecours AR
    Neuropsychiatry Neuropsychol Behav Neurol; 1998 Oct; 11(4):184-90. PubMed ID: 9845409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subtypes of dementia with Lewy bodies are associated with α-synuclein and tau distribution.
    Ferman TJ; Aoki N; Boeve BF; Aakre JA; Kantarci K; Graff-Radford J; Parisi JE; Van Gerpen JA; Graff-Radford NR; Uitti RJ; Pedraza O; Murray ME; Wszolek ZK; Reichard RR; Fields JA; Ross OA; Knopman DS; Petersen RC; Dickson DW
    Neurology; 2020 Jul; 95(2):e155-e165. PubMed ID: 32561678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TAR DNA-binding protein 43 and pathological subtype of Alzheimer's disease impact clinical features.
    Josephs KA; Whitwell JL; Tosakulwong N; Weigand SD; Murray ME; Liesinger AM; Petrucelli L; Senjem ML; Ivnik RJ; Parisi JE; Petersen RC; Dickson DW
    Ann Neurol; 2015 Nov; 78(5):697-709. PubMed ID: 26224156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive and Pathological Influences of Tau Pathology in Lewy Body Disorders.
    Coughlin D; Xie SX; Liang M; Williams A; Peterson C; Weintraub D; McMillan CT; Wolk DA; Akhtar RS; Hurtig HI; Branch Coslett H; Hamilton RH; Siderowf AD; Duda JE; Rascovsky K; Lee EB; Lee VM; Grossman M; Trojanowski JQ; Irwin DJ
    Ann Neurol; 2019 Feb; 85(2):259-271. PubMed ID: 30549331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurofibrillary pathology in Alzheimer disease with Lewy bodies: two subgroups.
    Gearing M; Lynn M; Mirra SS
    Arch Neurol; 1999 Feb; 56(2):203-8. PubMed ID: 10025425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Cortical β-Amyloid Protein in the Absence of Insoluble Deposits With Alzheimer Disease.
    Yu L; Petyuk VA; Tasaki S; Boyle PA; Gaiteri C; Schneider JA; De Jager PL; Bennett DA
    JAMA Neurol; 2019 Jul; 76(7):818-826. PubMed ID: 31009033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tau aggregation influences cognition and hippocampal atrophy in the absence of beta-amyloid: a clinico-imaging-pathological study of primary age-related tauopathy (PART).
    Josephs KA; Murray ME; Tosakulwong N; Whitwell JL; Knopman DS; Machulda MM; Weigand SD; Boeve BF; Kantarci K; Petrucelli L; Lowe VJ; Jack CR; Petersen RC; Parisi JE; Dickson DW
    Acta Neuropathol; 2017 May; 133(5):705-715. PubMed ID: 28160067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of APOE genotype on neuropathologic and neurochemical markers of Alzheimer disease.
    Tiraboschi P; Hansen LA; Masliah E; Alford M; Thal LJ; Corey-Bloom J
    Neurology; 2004 Jun; 62(11):1977-83. PubMed ID: 15184600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The hippocampal sparing subtype of Alzheimer's disease assessed in neuropathology and in vivo tau positron emission tomography: a systematic review.
    Ferreira D; Mohanty R; Murray ME; Nordberg A; Kantarci K; Westman E
    Acta Neuropathol Commun; 2022 Nov; 10(1):166. PubMed ID: 36376963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.